In CML, the BCR-ABL translocation does represent one source for leukemic neoantigens, and several epitopes from this fusion protein have been shown to elicit a T-cell response[52–55]. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.